Day: May 19, 2023

Autoscope Technologies Corporation Dividend Payment

Written by Customer Service on May 19, 2023. Posted in Dividend Reports And Estimates.

MINNEAPOLIS, May 19, 2023 (GLOBE NEWSWIRE) — Autoscope Technologies Corporation (OTCQX: AATC) today announced that the Board of Directors declared a dividend of $0.26 per share payable to shareholders of record as of May 30, 2023 with payment expected on or about June 6, 2023. This includes a payment of $0.13 per share for the 2023 first quarter dividend, which was delayed by the late filing of the Company’s 2022 Annual Report, including its audited financial statements, as well as an additional $0.13 per share for the current quarter. Executive Chair Andrew Berger said, “The Board is pleased to resume the payment of dividends now that the Company has successfully transitioned to the OTCQX Best Market platform. The Company increased its quarterly dividend from $0.12 per share to $0.13 per share and is now current on its commitment...

Carter Glatt to be Chairman Nominee of Global Hydrogen Energy LLC’s Post-Closing Board

Written by Customer Service on May 19, 2023. Posted in Mergers And Acquisitions.

Global Hydrogen is a Pure Play Hydrogen and Carbon Recovery Project Developer and Industrial Gas Supplier WEST PALM BEACH, Fla. & NEW YORK, May 19, 2023 (GLOBE NEWSWIRE) — Global Hydrogen Energy LLC (“Global Hydrogen”), which seeks to be a leader in the sustainable energy transition as a next-generation industrial gas supplier, today announced that Carter Glatt, CEO and Director of Dune Acquisition Corporation (Nasdaq: DUNEU, DUNE, DUNEW) (“Dune”), will serve as Chairman Nominee of its post-closing Board. On May 15, 2023, Dune, a special purpose acquisition company, and Global Hydrogen announced that they have entered into a definitive agreement for a business combination, which would result in Global Hydrogen becoming a publicly listed company. The combined company will be called Global Gas Corporation upon the closing...

Creative Realities Rejects Unsolicited Proposal by Pegasus Capital Advisors, L.P.

Written by Customer Service on May 19, 2023. Posted in Mergers And Acquisitions.

LOUISVILLE, Ky., May 19, 2023 (GLOBE NEWSWIRE) — As previously reported, on May 1, 2023, Creative Realities, Inc. (“Creative Realities,” “CRI,” or the “Company”) (NASDAQ: CREX, CREXW) received a revised proposal (the “Revised Proposal”) from Pegasus Capital Advisors, L.P., on behalf of itself and certain of its affiliates (collectively, “Pegasus”), to acquire all of the outstanding shares of common stock of the Company that are not owned by Pegasus for a purchase price of $2.85 per share in cash. The Revised Proposal followed an earlier proposal (the “Original Proposal”) from Pegasus to acquire all of the outstanding shares of common stock of the Company that are not owned by Pegasus for a purchase price of $2.49 per share in cash (adjusted for the Company’s 1-for-3 reverse stock split) effected March 27, 2023. The Original Proposal...

Ipsen receives positive opinion in Europe for Dysport® in the management of urinary incontinence in adults with neurogenic detrusor overactivity due to multiple sclerosis or spinal cord injury

Written by Customer Service on May 19, 2023. Posted in Public Companies.

Submission based on data from the pivotal international Phase III CONTENT clinical program, also recently published in European Urology1 CONTENT showed that Dysport® decreased incontinence episodes, detrusor pressure and increased bladder capacity versus placebo, and improved quality of life1PARIS, FRANCE, 9 June 2022 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced that Dysport® (abobotulinumtoxinA) has received positive opinion in Europe for the management of urinary incontinence (UI) in adults with neurogenic detrusor overactivity (NDO) due to spinal cord injury (SCI) (traumatic or non-traumatic) or multiple sclerosis (MS), who are regularly performing clean intermittent catheterization (CIC). This positive opinion for Dysport® now permits individual European country Health Authorities to grant national approvals, according to...

MCI Onehealth to Sell Operations in Alberta to WELL Health for $2 Million

Written by Customer Service on May 19, 2023. Posted in Public Companies.

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, May 19, 2023 (GLOBE NEWSWIRE) — MCI Onehealth Technologies Inc. (“MCI” or the “Company”) (TSX: DRDR), a clinician-led healthcare technology company focused on increasing access to and quality of healthcare, today announced that it has entered into a definitive agreement with WELL Health Technologies Corp. (“WELL”) for the sale of its operations in Alberta, including its five MCI The Doctor’s Office medical clinics, for a purchase price of $2 million (the “Transaction”). “This transaction will help support the operational needs of MCI Onehealth in the short- to medium-term, while preserving quality care for our loyal patient population by placing our Alberta clinics into the hands of an innovative, tech-forward Canadian healthcare leader...

Form 8.3 – [EMIS Group plc – 18 05 2023] – (CGWL)

Written by Customer Service on May 19, 2023. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree EMIS GROUP PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position held/dealing...

New Data at Heart Rhythm 2023 Suggests that Unipolar Signals May be Used for a More Precise, Accurate Approach to Treating Arrhythmias

Written by Customer Service on May 19, 2023. Posted in Public Companies.

Data from three abstracts highlight the potential of an optimized radiofrequency ablation technique for pulmonary vein isolation (PVI)Preservation of raw unipolar signal using BioSig’s PURE EP™ platform guidance enabled real-time tissue-specific feedback when conducting ablationCleveland, OH and Westport, CT, May 19, 2023 (GLOBE NEWSWIRE) — Researchers from Cleveland Clinic will be presenting data from three abstracts at Heart Rhythm 2023 that evaluated an optimized radiofrequency ablation technique for pulmonary vein isolation (PVI)—a type of ablation procedure used to treat atrial fibrillation (AF)—compared to the existing standard, the Ablation Index™. Researchers used BioSig Technologies, Inc. (NASDAQ: BSGM) proprietary PURE EP™ Platform for real-time tissue-specific feedback to achieve equal lesion...

Gulf & Pacific Equities Corp. reports on First Quarter Results with Revenue of $975,248 And Completes Additional Financing

Written by Customer Service on May 19, 2023. Posted in Public Companies.

Toronto, ON, May 19, 2023 (GLOBE NEWSWIRE) — Gulf & Pacific Equities Corp. (TSX-V: GUF) an established company focused on the acquisition, management and development of anchored shopping centres in Western Canada, reports a 3.7% increase in revenues to $975,248 in the quarter ended March 31, 2023, from $940,004 at the same period last year. Details of the three months financial results for fiscal 2023 and 2022 under International Financial Reporting Standards (IFRS), as summarized below, are also available at www.sedar.com or the company’s website www.gpequities.com. Three Months Ended (Unaudited) March 31, 2023 2022 Revenue $ 975,248 $ 940,004 Net Income (Loss) before fair value adjustment, other income items and income taxes $ (62,043 ) $ (74,684 )Net...

Aclarion Announces Non-Convertible Debt Financing to Achieve Three Critical Catalysts

Written by Customer Service on May 19, 2023. Posted in Public Companies.

Up to $2M Unsecured, Non-Convertible Bridge Debt With No Required Amortization Payments Financing Supports Execution of the 2023 Plan and the Achievement of Critical Milestones in Support of Definitive Growth Capital BROOMFIELD, CO, May 19, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, announced today the closing of up to a $2M unsecured, non-convertible debt financing that allows the Company to continue executing on its 2023 plan while providing the runway to achieve three critical milestones ahead of securing definitive growth capital. Brent Ness, CEO of Aclarion, said, “We have been executing...

Alterity Therapeutics CEO David Stamler to Present at the SHARE Series Monday Management Update on Monday, May 22, 2023

Written by Customer Service on May 19, 2023. Posted in Public Companies.

MELBOURNE, Australia and SAN FRANCISCO, May 19, 2023 (GLOBE NEWSWIRE) — Alterity Therapeutics, a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that David Stamler, M.D., Chief Executive Officer of Alterity will present at the SHARE Series Monday Management Update on Monday, May 22, 2023, at 11:00 am ET or 1:00am AEST Tuesday, May 23, 2023. This event is set in a fireside chat format and intended for retail and institutional investors. Investors will have the opportunity to ask questions during the chat. A link to the live and archived webcast may be accessed on the Alterity website under the Investors section Events and Presentations, or directly at https://www.openexchange.tv/share-series. An archived replay will be available for approximately 90 days...

Day: May 19, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice